3D Bioprinting

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates

Staff November 15, 2022

SAN DIEGO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology (3D biology) company focused...

Brinter Launches Upgraded Pneuma Triaxial Pro “Digital Pneuma Pro“ Bioprinting Head Capable Of Doing Microfluidic Manipulations To Enable More Personalized Tissue Cell Therapy And Transform How Diseases Are Treated

user June 22, 2022

Currently being piloted with selected customers, the new 3D bioprinting head provides a revolutionary approach to regenerative medicine and replacing...

Meeting The Challenges Of Bioprinting

user March 30, 2020

3D bioprinting offers opportunities such as testing treatment for diseases using artificially affected tissues, and through using bioink, it’s much...

3D Bioprinting

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates

Brinter Launches Upgraded Pneuma Triaxial Pro “Digital Pneuma Pro“ Bioprinting Head Capable Of Doing Microfluidic Manipulations To Enable More Personalized Tissue Cell Therapy And Transform How Diseases Are Treated

Meeting The Challenges Of Bioprinting

Body Vision Medical Signs Exclusive Distribution Agreement with AMCO Incorporated

CoreCare and Creative Solutions in Healthcare (CSNHC) Team up to Tackle New Minimum Data Set (MDS) Challenges

Cofertility’s “State of Egg Freezing 2024” Report Reveals 30% Increase in Egg Freezing Cycles Year-Over-Year

Curiteva Surpasses 1,000 Procedures With Inspire(R) Cervical Trabecular PEEK(TM) With HAFUSE(R) Technology

6 of the Top 10 Medical Device Manufacturers Rely On AcuityMD’s Commercial Intelligence Platform to Modernize Operations, Drive Revenue

You may have missed